Trials / Unknown
UnknownNCT00786552
Pemetrexed + Paclitaxel in Patients With Recurrent/Advanced Thyroid Cancer
Phase 2 Trial of Pemetrexed (Alimta™) Combined With Paclitaxel in Patients With Recurrent/Advanced Follicular, Papillary or Anaplastic Thyroid Cancer
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 47 (estimated)
- Sponsor
- University Hospital Schleswig-Holstein · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aims of this trial are to evaluate the efficacy and tolerability of pemetrexed + paclitaxel in patients with recurrent/advanced follicular, papillary or anaplastic thyroid cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | pemetrexed + paclitaxel | Pemetrexed 500 mg/m² i.v. over 10 minutes on day 8 Paclitaxel 90 mg/m² i.v. over 60 minutes on day1 and 8 |
Timeline
- Start date
- 2008-11-01
- Primary completion
- 2012-11-01
- Completion
- 2013-11-01
- First posted
- 2008-11-06
- Last updated
- 2011-01-20
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00786552. Inclusion in this directory is not an endorsement.